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In mature HIV-1 particles, viral capsid (CA) proteins form the conical core structure that
encapsidates two copies of the viral RNA genome. After fusion of the viral envelope
and cellular membranes, the CA core enters into the cytoplasm of the target cells. CA
proteins then interact with a variety of viral other protein as well as host factors, which
may either support or inhibit replication of the virus. Recent studies have revealed that CA
proteins are important not only for the uncoating step but also for the later nuclear import
step. Identification of proteins that interact with CA to fulfill these functions is, therefore,
important for understanding the unknown HIV-1 replication machinery. CA proteins can
also be targets of the host immune response. Notably, some HLA-restricted cytotoxic
T-lymphocyte (CTL) responses that recognize CA functional regions can greatly contribute
to delay in AIDS progression. The multi-functionality of the CA protein may limit the flexible
virus evolution and reduce the possibility of an escape mutant arising. The presence of
many functional regions in CA protein may make it a potential target for effective therapies.
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INTRODUCTION
The HIV-1 gag gene encodes the Gag protein, major structural
component of virus particles (Vogt, 1997; Scarlata and Carter,
2003; Engelman and Cherepanov, 2012). The Gag protein con-
sists of six functionally different proteins. Capsid (CA) is the
largest component of Gag protein, and forms core structure of
the mature HIV-1 particle. Recent studies have revealed that the
CA protein has multiple roles in the virus-host interaction at the
cellular or individual levels. In this mini-review, we are sum-
marizing the interaction of the CA and host cellular proteins
such as cyclophilin A (CypA), Nuclear pore proteins (Nups),
TRIM5alpha, and/or host immune response.
HIV-1 CAPSID PROTEINS CONSTITUTE THE VIRAL CORE
STRUCTURE
The HIV-1 Gag proteins are synthesized as Pr55Gag polypro-
tein in cytoplasm of the virus-producing cell, and are then
translocated to the plasma membrane. Subsequently, they are co-
assembled into virus particles, which bud and are then released
from the plasma membrane. Right after the budding and release
step from the virus producing cells, virus particles undergo a pro-
cess of maturation (Morikawa, 2003). The viral protease (PR)
cleaves the Gag polyprotein into six proteins: matrix (MA), CA,
nucleocapsid (NC), p6, p2, and p1. Virus morphology dramati-
cally changes as a result of the maturation process. In the mature
virus particles, CA proteins form a conical core structure encapsi-
dating two copies of the viral RNA genome associated by NC pro-
teins. The CA protein has N-terminal and C-terminal domains
(NTD and CTD, respectively), and the short flexible linker con-
nects between the two regions (Gitti et al., 1996; Momany et al.,
1996; Gamble et al., 1997). The CA proteins assemble into the
small units containing five or six monomers (Figure 1A) (Li et al.,
2000; Pornillos et al., 2009, 2011; Yeager, 2011). The core structure
is composed of approximately 250 units of hexamers, and 12 units
of pentamers at the both conical ends.
The mature virus particles can then infect to the new target
cells. The binding of the Env and receptors/co-receptors leads to
fusion of the viral envelope and cellular membranes, and sub-
sequently, the CA core enters the cytoplasm of the target cell.
The CA core interacts with a variety of cellular proteins at this
step (Mascarenhas andMusier-Forsyth, 2009). Before penetration
into new target cells, the viral core should be stable to pro-
tect the viral RNA genome from the outer environment (Koh
et al., 2000). However, after penetration, the core must be desta-
bilized to uncoat and release the viral genome at the correct time
for replication. Although spatial and temporal regulation of the
uncoating process is not yet well understood, this process presum-
ably depends on the interaction of CA with several host factors.
The identification of such host proteins is, therefore, likely to be
essential for understanding the HIV-1 replication cycle.
INTERACTION OF CA AND HOST FACTORS
CYCLOPHILIN A
Cyclophilin A (CypA) is a host cellular protein that car-
ries peptidyl-prolyl cis-trans isomerase (PPIase) activity and
is abundantly expressed in various types of cell, including T-
lymphocytes. CypA incorporates into HIV-1 particles via interac-
tion with pr55Gag protein (Luban et al., 1993; Franke et al., 1994;
Luban, 1996), binding at a site in the CA protein NTD, termed
the CypA-binding loop (Figures 1B and 2). The CypA-binding
loop is a proline-rich loop located between helices 4 and 5 in the
CA protein, with the proline residue at position 90 considered to
be the most important amino acid for CypA-binding (Grättinger
et al., 1999). Interference in CA-CypA-binding reduces HIV-1
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FIGURE 1 | CA proteins form hexamers and pentamers and schematic
model of CA interacting domains. (A) Hexameric/pentameric models
proposed from structural analysis of the HIV-1 core. Each core comprises
approximately 250 hexamers and exactly 12 pentamers. The accession
numbers of protein Databases are 3H47, 3P05. (B) Functional surfaces in the
CA protein. The gray circles indicate monomers of CA. NTD-NTD or CTD-NTD
interacting surfaces, CypA-binding loops, and hexamer-hexamer/pentamer
interacting surfaces are shown. CA; viral capsid; NTD; N-terminal domain,
CTD; C-terminal domain. The accession numbers of protein Database are
3DIK. The detailed map including each component is shown in Figure 2.
infection efficiency (Franke et al., 1994; Luban, 1996). Initial
studies to determine the role of CypA in HIV-1 infection focused
on CypA incorporated into virions, but later studies showed that
the target cellular CypA is more important for HIV-1 infection
(Sokolskaja et al., 2004; Hatziioannou et al., 2005). The exact role
of CypA in the HIV-1 replication is still unclear and remains a
subject of debate (Luban, 2007; Mascarenhas andMusier-Forsyth,
2009). One hypothesis is that the proline isomerase activity
induces a conformational change in the core structure, which
results in its destabilization and efficient viral uncoating in the
target cell cytoplasm. Interestingly, CypA is required for the repli-
cation HIV-1 group M virus, but not always necessary for the
HIV-1 group O or other simian immunodefficiency virus (SIV)
replication (Braaten et al., 1996). Besides, Takeuchi et al. (2012)
reported the opposing response to the CypA in HIV or SIV infec-
tion in different host cell species. Identification of the molecular
basis of CypA-dependent HIV-1 infection may also contribute to
understand the evolution of the HIV-1.
Nup358 AND OTHER FACTORS SUPPORTING NUCLEAR IMPORT
The lentiviruses, including HIV-1, are able to infect non-dividing
cells such as macrophages. The viral genome, consisting the
pre-integration complex (PIC), must move into the nucleus of
the target cell even in the non-dividing state, but molecular
mechanism of the nuclear import step has yet to be deter-
mined. Numerous studies have examined the requirements for
specific cellular proteins during HIV-1 nuclear import, including
nuclear transport proteins such as some importin family pro-
teins and Nups. It has been proposed that the PIC goes through
the nuclear pore on the nuclear membrane (De Iaco and Luban,
2011). One of the Nups, Nup358 (also known as RanBP2 or
RAN binding protein 2), is a cellular co-factor for the HIV-1
infection at the PIC nuclear import step (Hutten et al., 2009;
Zhang et al., 2010; Ocwieja et al., 2011; Schaller et al., 2011).
Nup358 is a relatively large protein (358 kDa) located on the cyto-
plasmic surface of the nuclear pore. Nup358 controls the cell
cycle, nuclear export, and transportin-dependent nuclear import.
Interestingly, Nup358 has a cyclophilin-like domain on its C-
terminal end. Schaller et al. (2011) revealed that Nup358 directly
binds to HIV-1 CA protein, with the viral acceptor being the
CypA-binding loop described above. The knockdown of Nup358
in target cells impairs HIV-1 infection at the nuclear import step,
and the migration of the PIC through the nuclear pore depends
on interaction of Nup358 and CA (Schaller et al., 2011). Although
the direct interaction of CA and Nup358 has now been iden-
tified, it is still unclear how Nup358 supports HIV-1 nuclear
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FIGURE 2 | Mapping of CA functional domains and twomajor protective
CTL alleles.Gray boxes show β-hairpin (amino acids 4–14) or helix structures
(H1–H11). Thickblackbars indicate theCTLepitopes restricted byeach allele (Llano
et al., 2009). The NTD-NTD, CTD-NTD, or hexamer-hexamer/pentamer interacting
regions are indicated. Three amino residues (N74, A105, and R132), which are
reported to change CypA dependency, are shown in circles (Schneidewind et al.,
2007; Yang and Aiken, 2007; Ambrose et al., 2012). The reference amino acids
sequences are from HXB2 (accession number; AB50258.1).
import. Furthermore, transportin-SR2 (TNPO3) was identified
as a HIV-1 co-factor that supports the nuclear import step by a
series of genome-wide siRNA screens, and TNPO3 interacts with
CA (Brass et al., 2008; Krishnan et al., 2010; Lee et al., 2010;
De Iaco and Luban, 2011). These observations suggest that the
functional analysis of CA should be expanded to include nuclear
import steps. Also, a recent study proposed a model in which
reverse transcription and uncoating processes are regulated by
each other or occurring at almost same time, at the perinuclear
location in the target cells (Hulme et al., 2011). Further analysis
into the role of CA in these steps, and their interactions with other
host proteins including Nups should help to clarify the molecular
mechanism of HIV-1 replication.
TRIM5alpha
HIV-1 infection is strikingly restricted in the non-human primate
cells. It had been predicted that the CA targeting dominant-
acting inhibitory factor(s) expressed in these cells (Kootstra
et al., 2003; Goff, 2004; Towers, 2007; Luban, 2012). Stremlau
et al. (2004) identified TRIM5alpha as a species-specific HIV-1
restriction factor from the cDNA library of rhesus monkey cells.
The other ortholog of TRIM5 gene (known as TRIM-Cyp), which
restricts HIV-1 infection, was also identified from owl mon-
key cells (Nisole et al., 2004; Sayah et al., 2004). TRIM5alpha
is a member of the tripartite motif-containing protein fam-
ily, and the N-teminal domain has E3 ubiquitin ligase activity
(Diaz-Griffero et al., 2006; Stremlau et al., 2006; Luban, 2012).
Since the TRIM-Cyp carries a CypA-like domain in the C-
terminal, it can targets the HIV-1 CA via the CypA-binding
loop (Sayah et al., 2004). Although, the C-terminal domain of
TRIM5alpha also has a function to recognize CA, its mecha-
nism had not been clarified despite of the numerous studies.
Ganser-Pornillos et al. (2011) proposed the TRIM5alpha lattice
model, in which a spontaneously formed cellular TRIM5alpha
hexameric lattice recognizes a surface of the incoming CA
core. The detailed mechanism of TRIM5alpha- or TRIM-
Cyp-mediated HIV-1 restriction after recognition of the core
structure is still unclear. Two distinct restriction stages have
been observed in both TRIM5alpha- or TRIM-Cyp-mediated
HIV-1 restriction (Anderson et al., 2006; Yap et al., 2006).
The unknown host factor may contribute to their restriction
mechanism.
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CA PROTEIN AND THE HOST IMMUNE RESPONSE
CAN THE CA ACTIVATE HOST INNATE IMMUNE SENSOR?
Manel et al. (2010) reported that the interaction of CypA and
newly synthesized Gag proteins induces the type I interferon
response to activate T-cells. They showed that the CypA-Gag
interaction in dendritic cells activates the IRF3 pathway. This was
the first report of an interaction between HIV-1 Gag (or CA)
and CypA playing a role in inducing the host innate immune
response. More recently, Pertel et al. (2011) showed that the
interaction of host cellular TRIM5 and CA stimulates AP-1 and
NF-κB signaling via the TAK-1 (also known as MAP3K7) path-
way. The proposed mechanism for this immune sensor is rather
complicated. In the presence of the heterodimeric E2 ubiquitin-
conjugating enzyme, UBC13/UEV1A, TRIM5alpha catalyzes the
synthesis of unattached K63-linked ubiquitin chains. The free
K63-linked ubiquitin chain activates the TAK1 kinase complex,
and the TAK-1-mediated signal then activates the inflamma-
tory cytokine transcription via the NF-κB and AP-1 pathway.
These two findings suggest that the Gag protein or core struc-
ture may be recognized by the TRIM5alpha or CypA that is acting
as a pathogen recognition receptor for the host innate immune
response. Further work in this area may contribute to the devel-
opment of new therapeutic strategies utilizing the host immune
response.
MAJOR PROTECTIVE CYTOTOXIC T-LYMPHOCYTE (CTL) ALLELES
TARGETING CA PROTEIN
The host cytotoxic T-lymphocyte (CTL) response is a major
effector to control HIV-1 replication in vivo (Borrow et al.,
1994; Goulder and Watkins, 2008). CD8+ CTLs recognize the
antigenic peptides in the context of the class I major histocom-
patibility complex (MHC). The CTL escape mutations occur-
ring HIV-1 infection has been well documented (Leslie et al.,
2004; Gao et al., 2005). In many cases, the replication fitness
of the escape mutants is lower than that of the parental viruses
(Leslie et al., 2004). Since the CTLs recognize the target viral
peptides presented by the MHC on the surface of the virus-
infected cells, the efficiency of the CTL response closely depends
on the host MHC (human leukocyte antigen, HLA, in human)
alleles. Numerous studies show that some HLA alleles, such as
HLA-B∗27 and HLA-B∗57, have stronger protective effects than
that of other HLA alleles (Carrington and O’Brien, 2003; Gao
et al., 2005; Goulder and Watkins, 2008). HIV-1-specific CD8+
T-cell responses restricted by these alleles provide a probable
mechanism for the protection of HIV-1 infected carriers from
disease progression. Notably, HLA-B∗27 and HLA-B∗57 target-
ing epitopes are located in the viral CA protein (mapped in
Figure 2). The major escape variant from HLA-B∗27, R132K, has
been altered CypA dependency for viral infection (Schneidewind
et al., 2007). The three major highly conserved epitopes of HLA-
B∗57, IW9, KF11, and TW10 are located distant regions in CA.
In these epitopes, IW9 and KF11 locate the region that has
been identified as the CA NTD-NTD interacting surface. Escape
mutations in those regions may confer a structural disadvan-
tage on the virus, one which impairs infectivity (Llano et al.,
2009; Pornillos et al., 2009; Brennan et al., 2012). TW10 locates
the outer surface of the CA core structure, and Brockman et al.
(2007) showed that escape mutants in this region also alter the
CypA dependency for its replication. In addition, Battivelli et al.
(2011) reported that the mutations in TW10 increase the sensi-
tivity to the potent host cellular restriction factor TRIM5alpha.
Thus, escape mutations in CA often induce impairment of viral
replication as a result of a failure of interactions with viral or
host factors. More generally, it could be said that the interaction
between CA and viral or host proteins limits the evolutionary
flexibility of the virus. The CTL efficiency is not solely depend-
ing on the choice of the epitopes. Even though various factors
impact on effective CTL responses such as presentation efficiency
of the epitopes, the low evolutional flexibility of the target epi-
tope regions could be important factor for selecting effective CTL
responses.
PERSPECTIVE
For optimization of anti-HIV-1 therapies, much remains to
be studied about the function of each HIV-1 encoded pro-
tein and its interacting partner. It is widely known that escape
mutants arising under selective pressure from the host immune
response or anti-viral therapies often lose the fitness for repli-
cation. Recent advances in structural and genomic analyses
expand our understanding of viral and host protein interac-
tions. When the host immune response targets such a multi-
functional protein, like CA, the possibilities for generating a
successful escape mutation may be limited. In fact, two major
protective CTL alleles target a region that is functionally impor-
tant for HIV-1 replication. It can be considered that the multi-
functionality of the protein limits the “robustness” of the HIV-1
as a living organism. From this point of view, further func-
tional analysis of the CA protein, as well as CA-host protein
interactions, may contribute to establish better therapies for
HIV-1.
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